As sIRB mandates reshape the clinical trial landscape, study teams must navigate unique challenges while...
Read More...
Assessing and reporting adverse events (AEs) in clinical trials is critical to ensuring the study...
Read More...
Oncology trials face unique hurdles in innovation, enrollment, and endpoints, requiring strategic planning to address...
Read More...
A common trope in sci-fi movies involves concerns about potentially smashing into uncharted objects while...
Read More...Advarra has policies and processes in place to keep IRB operations functioning as normal during...
Read More...In this blog we discuss unique issues that research involving emerging infectious diseases like coronavirus...
Read More...The Northwest Association for Biomedical Research (NWABR) has appointed James Riddle, Advarra VP of Institutional...
Read More...Compliance with the single IRB mandate for cooperative research, as outlined in the revised Common...
Read More...NIH has updated its human subjects research decision tool to reflect changes brought about by...
Read More...Advarra has updated its IRB Handbook for Investigators, Institutions, Sponsors, and Sponsors’ Representatives to incorporate...
Read More...